SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Andréasson S.) "

Sökning: WFRF:(Andréasson S.)

  • Resultat 1-10 av 300
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Elhai, M, et al. (författare)
  • Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
  • 2019
  • Ingår i: Annals of the rheumatic diseases. - : BMJ. - 1468-2060 .- 0003-4967. ; 78:7, s. 979-987
  • Tidskriftsartikel (refereegranskat)abstract
    • To assess the safety and efficacy of rituximab in systemic sclerosis (SSc) in clinical practice.MethodsWe performed a prospective study including patients with SSc from the European Scleroderma Trials and Research (EUSTAR) network treated with rituximab and matched with untreated patients with SSc. The main outcomes measures were adverse events, skin fibrosis improvement, lung fibrosis worsening and steroids use among propensity score-matched patients treated or not with rituximab.Results254 patients were treated with rituximab, in 58% for lung and in 32% for skin involvement. After a median follow-up of 2 years, about 70% of the patients had no side effect. Comparison of treated patients with 9575 propensity-score matched patients showed that patients treated with rituximab were more likely to have skin fibrosis improvement (22.7 vs 14.03 events per 100 person-years; OR: 2.79 [1.47–5.32]; p=0.002). Treated patients did not have significantly different rates of decrease in forced vital capacity (FVC)>10% (OR: 1.03 [0.55–1.94]; p=0.93) nor in carbon monoxide diffusing capacity (DLCO) decrease. Patients having received rituximab were more prone to stop or decrease steroids (OR: 2.34 [1.56–3.53], p<0.0001). Patients treated concomitantly with mycophenolate mofetil had a trend for better outcomes as compared with patients receiving rituximab alone (delta FVC: 5.22 [0.83–9.62]; p=0.019 as compared with controls vs 3 [0.66–5.35]; p=0.012).ConclusionRituximab use was associated with a good safety profile in this large SSc-cohort. Significant change was observed on skin fibrosis, but not on lung. However, the limitation is the observational design. The potential stabilisation of lung fibrosis by rituximab has to be addressed by a randomised trial.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  • Vinko, S. M., et al. (författare)
  • Electronic Structure of an XUV Photogenerated Solid-Density Aluminum Plasma
  • 2010
  • Ingår i: Physical Review Letters. - 0031-9007 .- 1079-7114. ; 104:22, s. 225001-
  • Tidskriftsartikel (refereegranskat)abstract
    • By use of high intensity XUV radiation from the FLASH free-electron laser at DESY, we have created highly excited exotic states of matter in solid-density aluminum samples. The XUV intensity is sufficiently high to excite an inner-shell electron from a large fraction of the atoms in the focal region. We show that soft-x-ray emission spectroscopy measurements reveal the electronic temperature and density of this highly excited system immediately after the excitation pulse, with detailed calculations of the electronic structure, based on finite-temperature density functional theory, in good agreement with the experimental results.
  •  
6.
  • Vinko, S. M., et al. (författare)
  • Time-Resolved XUV Opacity Measurements of Warm Dense Aluminum
  • 2020
  • Ingår i: Physical Review Letters. - : American Physical Society. - 1079-7114 .- 0031-9007. ; 124:22
  • Tidskriftsartikel (refereegranskat)abstract
    • The free-free opacity in plasmas is fundamental to our understanding of energy transport in stellar interiors and for inertial confinement fusion research. However, theoretical predictions in the challenging dense plasma regime are conflicting and there is a dearth of accurate experimental data to allow for direct model validation. Here we present time-resolved transmission measurements in solid-density Al heated by an XUV free-electron laser. We use a novel functional optimization approach to extract the temperature-dependent absorption coefficient directly from an oversampled pool of single-shot measurements, and find a pronounced enhancement of the opacity as the plasma is heated to temperatures of order of the Fermi energy. Plasma heating and opacity enhancement are observed on ultrafast timescales, within the duration of the femtosecond XUV pulse. We attribute further rises in the opacity on ps timescales to melt and the formation of warm dense matter.
  •  
7.
  • Hajkova, V., et al. (författare)
  • X-ray laser-induced ablation of lead compounds
  • 2011
  • Ingår i: DAMAGE TO VUV, EUV, AND X-RAY OPTICS III. - : SPIE.
  • Konferensbidrag (refereegranskat)abstract
    • The recent commissioning of a X-ray free-electron laser triggered an extensive research in the area of X-ray ablation of high-Z, high-density materials. Such compounds should be used to shorten an effective attenuation length for obtaining clean ablation imprints required for the focused beam analysis. Compounds of lead (Z=82) represent the materials of first choice. In this contribution, single-shot ablation thresholds are reported for PbWO(4) and PbI(2) exposed to ultra-short pulses of extreme ultraviolet radiation and X-rays at FLASH and LCLS facilities, respectively. Interestingly, the threshold reaches only 0.11 J/cm(2) at 1.55 nm in lead tungstate although a value of 0.4 J/cm(2) is expected according to the wavelength dependence of an attenuation length and the threshold value determined in the XUV spectral region, i.e., 79 mJ/cm(2) at a FEL wavelength of 13.5 nm. Mechanisms of ablation processes are discussed to explain this discrepancy. Lead iodide shows at 1.55 nm significantly lower ablation threshold than tungstate although an attenuation length of the radiation is in both materials quite the same. Lower thermal and radiation stability of PbI(2) is responsible for this finding.
  •  
8.
  • Hong, S. J., et al. (författare)
  • TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels
  • 2021
  • Ingår i: Alzheimers & Dementia. - : Wiley. - 1552-5260 .- 1552-5279. ; 17:10, s. 1628-1640
  • Tidskriftsartikel (refereegranskat)abstract
    • Introduction Neurofilament light (NfL), chitinase-3-like protein 1 (YKL-40), and neurogranin (Ng) are biomarkers for Alzheimer's disease (AD) to monitor axonal damage, astroglial activation, and synaptic degeneration, respectively. Methods We performed genome-wide association studies (GWAS) using DNA and cerebrospinal fluid (CSF) samples from the EMIF-AD Multimodal Biomarker Discovery study for discovery, and the Alzheimer's Disease Neuroimaging Initiative study for validation analyses. GWAS were performed for all three CSF biomarkers using linear regression models adjusting for relevant covariates. Results We identify novel genome-wide significant associations between DNA variants in TMEM106B and CSF levels of NfL, and between CPOX and YKL-40. We confirm previous work suggesting that YKL-40 levels are associated with DNA variants in CHI3L1. Discussion Our study provides important new insights into the genetic architecture underlying interindividual variation in three AD-related CSF biomarkers. In particular, our data shed light on the sequence of events regarding the initiation and progression of neuropathological processes relevant in AD.
  •  
9.
  • Bos, I., et al. (författare)
  • Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
  • 2019
  • Ingår i: Alzheimers & Dementia. - : Wiley. - 1552-5260 .- 1552-5279. ; 15:5, s. 644-654
  • Tidskriftsartikel (refereegranskat)abstract
    • Introduction: We investigated relations between amyloid-beta (A beta) status, apolipoprotein E (APOE) e4, and cognition, with cerebrospinal fluid markers of neurogranin (Ng), neurofilament light (NFL), YKL-40, and total tau (T-tau). Methods: We included 770 individuals with normal cognition, mild cognitive impairment, and Alzheimer's disease (AD)-type dementia from the EMIF-AD Multimodal Biomarker Discovery study. We tested the association of Ng, NFL, YKL-40, and T-tau with A beta status (Ab beta- vs. A beta+), clinical diagnosis APOE epsilon 4 carriership, baseline cognition, and change in cognition. Results: Ng and T-tau distinguished between A beta+ from A beta- individuals in each clinical group, whereas NFL and YKL-40 were associated with A beta+ in nondemented individuals only. APOE epsilon 4 carriership did not influence NFL, Ng, and YKL-40 in A beta+ individuals. NFL was the best predictor of cognitive decline in A beta+ individuals across the cognitive spectrum. Discussion: Axonal degeneration, synaptic dysfunction, astroglial activation, and altered tau metabolism are involved already in preclinical AD. NFL may be a useful prognostic marker. (C) 2019 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
  •  
10.
  • Boulo, S., et al. (författare)
  • First amyloid β1-42 certified reference material for re-calibrating commercial immunoassays
  • 2020
  • Ingår i: Alzheimer's and Dementia. - : Wiley. - 1552-5260 .- 1552-5279. ; 16:11, s. 1493-1503
  • Tidskriftsartikel (refereegranskat)abstract
    • Introduction: Reference materials based on human cerebrospinal fluid were certified for the mass concentration of amyloid beta (Aβ)1-42 (Aβ42). They are intended to be used to calibrate diagnostic assays for Aβ42. Methods: The three certified reference materials (CRMs), ERM-DA480/IFCC, ERM-DA481/IFCC and ERM-DA482/IFCC, were prepared at three concentration levels and characterized using isotope dilution mass spectrometry methods. Roche, EUROIMMUN, and Fujirebio used the three CRMs to re-calibrate their immunoassays. Results: The certified Aβ42 mass concentrations in ERM-DA480/IFCC, ERM-DA481/IFCC, and ERM-DA482/IFCC are 0.45, 0.72, and 1.22 μg/L, respectively, with expanded uncertainties (k = 2) of 0.07, 0.11, and 0.18 μg/L, respectively. Before re-calibration, a good correlation (Pearson's r > 0.97), yet large biases, were observed between results from different commercial assays. After re-calibration the between-assay bias was reduced to < 5%. Discussion: The Aβ42 CRMs can ensure the equivalence of results between methods and across platforms for the measurement of Aβ42. © 2020 the Alzheimer's Association
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 300
Typ av publikation
tidskriftsartikel (263)
konferensbidrag (28)
rapport (3)
forskningsöversikt (2)
bok (1)
annan publikation (1)
visa fler...
doktorsavhandling (1)
bokkapitel (1)
visa färre...
Typ av innehåll
refereegranskat (250)
övrigt vetenskapligt/konstnärligt (49)
populärvet., debatt m.m. (1)
Författare/redaktör
Andreasson, S (122)
Hajdu, Janos (28)
Andreasson, Jakob (26)
Zetterberg, Henrik, ... (23)
Andreasson, Ulf, 196 ... (23)
Blennow, Kaj, 1958 (22)
visa fler...
Timneanu, Nicusor (22)
Maia, Filipe R. N. C ... (18)
Seibert, M Marvin (15)
Barty, Anton (15)
Allebeck, P (14)
Andreasson, B (13)
Andreasson, Joakim, ... (13)
Kirian, Richard A. (13)
Hallgren, M. (12)
Moore, A. L. (12)
Moore, T. A. (12)
Gust, D. (12)
Svenda, Martin (12)
Chapman, Henry N. (12)
Bostedt, Christoph (12)
Ekeberg, Tomas (11)
Andreasson, Jakob, 1 ... (11)
Andréasson, Sten (10)
Andreasson, A (10)
Wallin, E (9)
Hammarberg, A (9)
Aquila, Andrew (9)
Rudenko, Artem (9)
Rolles, Daniel (9)
Straight, S. D. (9)
Martin, Andrew V. (9)
Hartmann, Robert (9)
Bozek, John D. (9)
DePonte, Daniel P. (9)
Samuelsson, J (8)
Bielecki, Johan (8)
Foucar, Lutz (8)
Andreasson, J. (7)
Caleman, Carl (7)
Andreasson, K (7)
Zweegman, S (7)
Harrison, C (7)
Andersson, Inger (7)
Rudek, Benedikt (7)
Chapman, H. N. (7)
Hunter, Mark S. (7)
Fromme, Petra (7)
Epp, Sascha W. (7)
Holl, Peter (7)
visa färre...
Lärosäte
Karolinska Institutet (136)
Uppsala universitet (56)
Göteborgs universitet (45)
Lunds universitet (34)
Chalmers tekniska högskola (32)
Kungliga Tekniska Högskolan (12)
visa fler...
Linköpings universitet (11)
Stockholms universitet (6)
Umeå universitet (5)
Örebro universitet (5)
Högskolan i Borås (3)
Luleå tekniska universitet (2)
Mittuniversitetet (2)
Linnéuniversitetet (2)
Sveriges Lantbruksuniversitet (2)
Högskolan i Halmstad (1)
RISE (1)
Röda Korsets Högskola (1)
visa färre...
Språk
Engelska (293)
Svenska (4)
Odefinierat språk (3)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (78)
Naturvetenskap (69)
Teknik (10)
Samhällsvetenskap (9)
Lantbruksvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy